Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
184
datasets available to search
ShareScore release 0.9.0
Dataset results
184 results for “Hyperparathyroidism”
A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis
ClinicalTrials.gov study NCT00042653. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients
ClinicalTrials.gov study NCT00037635. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Effect of Mechanical Loading on vBMD and Geometry in Patients With Primary Hyperparathyroidism
ClinicalTrials.gov study NCT05426512. IPD Sharing: NO. Countries: 0. Publications: 1.
ACHIEVE: Optimizing the Treatment of Secondary Hyperparathyroidism
ClinicalTrials.gov study NCT00135304. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Autofluorescence in Surgery for Primary Hyperparathyroidism
ClinicalTrials.gov study NCT06230380. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Morbidity Related to Secondary Hyperparathyroidism After Renal Transplantation
ClinicalTrials.gov study NCT01741064. IPD Sharing: Not stated. Countries: 0. Publications: 4.
Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose
ClinicalTrials.gov study NCT00891813. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer
ClinicalTrials.gov study NCT00037518. IPD Sharing: Not stated. Countries: 0. Publications: 3.
Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis
ClinicalTrials.gov study NCT00537979. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT)
ClinicalTrials.gov study NCT03299244. IPD Sharing: YES. Countries: 6. Publications: 0.
Efficacy and Safety of Ultrasonic Ablation to Treat Secondary Hyperparathyroidism in Chronic Kidney Disease Patients
ClinicalTrials.gov study NCT01640184. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT)
ClinicalTrials.gov study NCT01219855. IPD Sharing: NO. Countries: 1. Publications: 0.
Parathyroidectomy Restores Skeletal Muscle Strength and Transcriptome in Individuals with Primary Hyperparathyroidism
GEO Series GSE283368. Homo sapiens. 36 samples. Type: Expression profiling by high throughput sequencing.
Data from: Predictors of nephrolithiasis, osteoporosis and mortality in primary hyperparathyroidism
Context: Primary Hyperparathyroidism (PHPT) has a prevalence of 0.86% and is associated with increased risk of nephrolithiasis and osteoporosis. PHPT may also be associated with an increased risk of cardiovascular disease and mortality. Objective: To identify risk factors for nephrolithiasis, osteoporosis and mortality in PHPT. Design: Retrospective cohort study. Setting: University teaching hospital. Patients: PHPT presenting between 2006 – 2014 (n = 611). Main outcome measures: Assessment of nephrolithiasis, osteoporosis and mortality. Results: 13.9% of PHPT patients had nephrolithiasis. Most had already documented stone disease and only 4.7% of asymptomatic patients screened for renal stones had calculi identified, not very dissimilar to the rate in the non-PHPT population. Younger age (P < 0.001) and male gender (P = 0.003) were the only independent predictors of nephrolithiasis. 48.4% of patients with DXA data had osteoporosis (223/461). Older age (P < 0.001), lower BMI (P = 0.002) and lower creatinine (P = 0.006) were independently associated with a diagnosis of osteoporosis. Higher PTH was independently associated with lower Z-score at the hip (P = 0.009), but otherwise calcium and PTH were not associated with lower Z-score. Mortality in PHPT was associated with older age (P < 0.008), social deprivation (P = 0.028) and adjusted calcium (P = 0.009) but not independently with PTH at diagnosis. Conclusions: Screening for nephrolithiasis has a low yield, particularly in lower risk patients. Osteoporosis is only minimally associated with biochemical indices of PHPT. Mortality is associated with higher calcium (and possibly vitamin D deficiency) but not PTH.
Diagnostic Performance of [11C]Choline PET/CT In the Preoperative Assessment of Primary Hyperparathyroidism
ClinicalTrials.gov study NCT06647966. IPD Sharing: NO. Countries: 1. Publications: 0.
Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary Hyperparathyroidism
ClinicalTrials.gov study NCT01220050. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pilot Study: Hypovitaminosis D, Hyperparathyroidism and Hypomagnesemia in Patients With Congestive Heart Failure
ClinicalTrials.gov study NCT00887666. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Primary Hyperparathyroidism and Gut Microbiota
ClinicalTrials.gov study NCT04948671. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
18F-choline Positron-emission-tomography - Computed-tomography Compared to Conventional Imaging for Localizing Diseased Parathyroid Glands in Primary Hyperparathyroidism
ClinicalTrials.gov study NCT07138820. IPD Sharing: NO. Countries: 1. Publications: 0.
Single-Cell Sequence Technology Used to Reveal Heterogeneity of Secondary Hyperparathyroidism
ClinicalTrials.gov study NCT06130683. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.